🔎 Trials Near Me

Akèy › Maladi fwa steatotik › Indiana › Indianapolis

Etid klinik pou Maladi fwa steatotik nan Indianapolis, IN

6 etid pou Maladi fwa steatotik ap chèche patisipan nan sit nan ak bò kote Indianapolis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Ap rekriteFaz 3
  • Indiana University Health University Hospital, Indianapolis
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Ap rekriteFaz 3
  • Akero Clinical Study Site, Indianapolis
Laj 18 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT06528314

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

Ap rekriteFaz 2
  • GSK Investigational Site, Indianapolis
Laj 18 a 70 · Tout sèks · Mizajou Aug 3, 2026 · NCT06613698

Fibrosis Lessens After Metabolic Surgery

Ap rekriteFaz 4Volontè an sante akeyi
  • Indiana University, Indianapolis
Laj 18 a 75 · Tout sèks · Mizajou Jul 31, 2026 · NCT06374875

Non-Invasive Quantification of Liver Health in NASH (N-QUAN)

Ap rekrite
  • Indiana University Health, Indianapolis
Laj 18 a 75 · Tout sèks · Mizajou May 19, 2026 · NCT04054310

Etid Maladi fwa steatotik nan lòt vil

Lòt etid nan Indianapolis

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.